{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Analyze different types of melanocytic tumors associated with loss of BAP1 expression by immunohistochemistry
  2. Interpret the significance of loss of BAP1 in benign and malignant melanocytic lesions
  3. Distinguish melanoma from nevus displaying loss of BAP1, with obvious consequences in the treatment of these patients.
Price: $15.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: AJD0319
Published: March 2019
Expires: 1/1/2026
Required Passing Score: 4/5 (80%)
Authors: Phyu P. Aung, MD, Priyadharsini Nagarajan, MD, PhD, Michael T. Tetzlaff, MD, PhD, Jonathan L. Curry, MD, Guilin Tang, MD, Zied Abdullaev, PhD, Svetlana D. Pack, PhD, Doina Ivan, MD, Victor G. Prieto, MD, PhD and Carlos A. Torres-Cabala, MD
Categories: Cancer , Dermatology , Pathology
Topics: Cancer , Melanoma